Acumen Pharmaceuticals Inc (NASDAQ:ABOS)

2.83
Delayed Data
As of Dec 06
 +0.18 / +6.77%
Today’s Change
1.81
Today|||52-Week Range
11.31
-47.59%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Acumen Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 22.00 and a low estimate of 14.00. The median estimate represents a +465.37% increase from the last price of 2.83.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Acumen Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.36
Sales
$0.00
Reporting Date
Mar 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -49.00%
 
 
 
 
 
 
Growthannually -25.31%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.